Catalyst Insights
A Catalyst Clinical Research Newsletter
Welcome to the launch of our Catalyst Insights newsletter! We will be sharing upcoming events and news about what’s happening in our world of clinical research. This month is a special one as we recently announced a new CEO for Catalyst Clinical Research!?
Nik Morton assumed the CEO role for Catalyst Clinical Research on 12 February 2024. Prior to this move Nik served as the company’s President and COO. Having joined Catalyst as its COO in 2022.
Prior to Nik joining Catalyst, he held strategic roles at a large CRO, including global leaderships roles for biostatistics, programming, medical writing, including functional services delivery; hematology and oncology project management overseeing full-service delivery; site and patient access, accountable for selecting the best sites for enrolling and for activating in the shortest cycle times; and the design and implementation of digitally enabled and decentralized clinical trials.
We also announced some leadership changes for Catalyst Oncology and Catalyst Flex. Read about the many exciting changes happening at Catalyst! ?
White paper: “Enhancing the Data Journey in Oncology Clinical Trials”?
And while you are in the reading mode, if you haven’t had a chance yet, visit our website to access our white paper about the importance of EHR to EDC clinical trials.
Office Opening in Kochi, India
Catalyst opened an office in Kochi, India, in January. This office addition is part of a new chapter for our growing India operations .?Like the Trivandrum office, Kochi will be shared by both Catalyst services and the Genpro Research product team.?